Life Sciences Innovation Fund II, L.P. — Form D
Life Sciences Innovation Fund II, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2021-07-16. $10.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-07-16
- Form: D
- Accession: 0000905718-21-000918
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $10.8M
- Investors: 38
- Date of first sale: 2021-05-17
- Security types: fund interests
- SEC file number: 021-406537
Issuer
- Name: Life Sciences Innovation Fund II, L.P.
- CIK: 0001870508
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 527 MADISON AVENUE, NEW YORK, NY, 10022
- Phone: (212) 319-6625
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| David Greenhouse | Director | New York, NY |
| Austin Marxe | Director | New York, NY |
| Adam Stettner | Director | Solana Beach, CA |
| David Greenhouse | Executive Officer | New York, NY |
| Austin Marxe | Executive Officer | New York, NY |
| Adam Stettner | Executive Officer | Solana Beach, CA |
| David Sable | Director | Natick, MA |
| David Sable | Executive Officer | Natick, MA |
| David M Greenhouse | Director | New York, NY |
| David M Greenhouse | Executive Officer | New York, NY |
| - Life Sciences Innovation GP LLC | Director | New York, NY |
| - Life Sciences Innovation GP LLC | Executive Officer | New York, NY |
| Adam M Stettner | Director | New York, NY |
| Adam M Stettner | Executive Officer | New York, NY |
| - AWM Investment Company, Inc. | Executive Officer | New York, NY |
| Austin W Marxe | Director | New York, NY |
| Austin W Marxe | Executive Officer | New York, NY |
Other filings by this issuer (1)
More